Cyp2c9 Genotyping

CYP2C9 Genotyping is a pharmacogenetic testing method that identifies genetic variants in the CYP2C9 gene to predict an individual’s metabolic capacity for certain drugs, particularly oral anticoagulants and nonsteroidal anti-inflammatory drugs.

764

Publications

49.1K

Citations

4K

Authors

1.3K

Institutions

Publications per year

2017–2026

128

Variants

Cyp2c9 Genotype Testing

Authors

4K

  1. AE
    Allan E. Rettie

    University of Washington, United States

    22 publications · 2.3K citations

    20

    h-index

  2. JK
    Julia Kirchheiner

    Charité - Universitätsmedizin Berlin, Germany

    16 publications · 1.4K citations

    15

    h-index

  3. JB
    Jung‐Woo Bae

    Sungkyunkwan University, South Korea

    17 publications · 519 citations

    15

    h-index

  4. SL
    Seok‐Yong Lee

    Sungkyunkwan University, South Korea

    18 publications · 532 citations

    15

    h-index

  5. CJ
    Choon‐Gon Jang

    Sungkyunkwan University, South Korea

    18 publications · 532 citations

    15

    h-index

1–5 of 4K

Venues

  1. Clinical Pharmacology & Therapeutics

    CPT · 71 publications · 9.6K citations

    53

    h-index

  2. European Journal of Clinical Pharmacology

    45 publications · 2.2K citations

    31

    h-index

  3. Pharmacogenomics

    37 publications · 2.2K citations

    28

    h-index

  4. Pharmacogenetics

    28 publications · 4.3K citations

    27

    h-index

  5. British Journal of Clinical Pharmacology

    BJCP · 28 publications · 2.2K citations

    24

    h-index

1–5